Key result
Among 2,446 STEMI patients, 95%-97% had at least one modifiable risk factor, and the prevalence of smoking, hypertension, dyslipidemia, and metabolic syndrome increased significantly from 2005 to 2016.
Why the study?
STEMI is a leading cause of morbidity and mortality in developed countries, and understanding the prevalence and trends of major risk factors may facilitate primary and secondary prevention.
Observational (n=2,446)
No
The vast majority of STEMI patients present with at least one modifiable risk factor, with prevalence rates of smoking, hypertension, and dyslipidemia increasing over time, underscoring the critical need for effective primary and secondary prevention strategies.
Renewed prevention focus may be warranted in STEMI; extends temporal trends yet remains hypothesis-generating for intervention impact.
BACKGROUND: ST-segment elevation myocardial infarction (STEMI) is one of the leading causes of morbidity and mortality in developed countries. Therefore, understanding the prevalence and trends of major risk factors may facilitate primary and secondary prevention of STEMI. METHODS: In the present study, 2446 consecutive patients with STEMI admitted to Far Eastern Memorial Hospital from 2005 to 2016 were enrolled. A comprehensive analysis of the prevalence, distribution, and trends over time of major risk factors as well as Framingham risk scores of all patients was performed. RESULTS: The most prevalent risk factors were male sex, hypertension (HTN), smoking, age, dyslipidemia, and diabetes mellitus. Furthermore, 95%-97% of the patients had at least one modifiable risk factor, and < 1% of the patients did not have any identifiable risk factors. The prevalence trends of smoking, HTN, dyslipidemia, and metabolic syndrome increased significantly from 2005 to 2016. Seasonal variation analysis revealed a 15% increase in STEMI cases between January and March compared with those between April and December. Isolated low high- density lipoprotein-cholesterol syndrome was the second most common type of dyslipidemia, with a prevalence rate of 16.6%. Moreover, only 56.8% of the male and 32% of the female patients were in the Framingham high-risk group. CONCLUSIONS: A high prevalence rate and an increasing trend of modifiable risk factors resulted in a high number of STEMI cases at our hospital. Controlling modifiable risk factors and improving nontraditional risk factor detection could facilitate primary and secondary preventions for STEMI.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2020) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=2,446). Major cardiovascular risk factors was evaluated on Prevalence, distribution, and trends over time of major risk factors and Framingham risk scores. Among 2,446 STEMI patients, 95%-97% had at least one modifiable risk factor, and the prevalence of smoking, hypertension, dyslipidemia, and metabolic syndrome increased significantly from 2005 to 2016.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: